Form of Award NoticeAmgen Inc • May 3rd, 2013 • Biological products, (no disgnostic substances) • Delaware
This notice of Award (the “Award Notice”) sets forth certain details relating to the grant by the Company to you of the Award identified below, pursuant to the Plan. The terms of this Award Notice are incorporated into the Agreement that accompanies this Award Notice and made part of the Agreement. Capitalized terms used in this Award Notice that are not otherwise defined in this Award Notice have the meanings given to such terms in the Agreement.
Form of Award NoticeAmgen Inc • May 3rd, 2013 • Biological products, (no disgnostic substances)
This notice of Award (the “Award Notice”) sets forth certain details relating to the grant by the Company to you of the Award identified below, pursuant to the Plan. The terms of this Award Notice are incorporated into the Agreement that accompanies this Award Notice and made part of the Agreement. Capitalized terms used in this Award Notice that are not otherwise defined in this Award Notice have the meanings given to such terms in the Agreement.
Form of Award NoticePerformance Unit Agreement • May 3rd, 2013 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
This notice of Award (the “Award Notice”) sets forth certain details relating to the grant by the Company to you of the Award identified below, pursuant to the Plan. The terms of this Award Notice are incorporated into the Agreement that accompanies this Award Notice and made part of the Agreement. Capitalized terms used in this Award Notice that are not otherwise defined in this Award Notice have the meanings given to such terms in the Agreement.
RESTRICTED STOCK UNIT AGREEMENT (Director Equity Incentive Program)Restricted Stock Unit Agreement • May 3rd, 2013 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
On this __ day of _______________ (the “Grant Date”), Amgen Inc., a Delaware corporation (the “Company”), pursuant to its Amgen 2009 Director Equity Incentive Program (as amended and/or restated from time to time, the “Program”) which implements the Amgen Inc. 2009 Equity Incentive Plan, as amended and/or restated from time to time (the “Plan”), has granted to you, the grantee named above, _____________ restricted stock units (the “Units”) with respect to ______________ Shares on the terms and conditions set forth in this Restricted Stock Unit Agreement, including any appendix hereto (as further described in Section XIV below) containing special terms and conditions applicable to your country (collectively, this “Agreement”), and the Plan. Capitalized terms not defined herein shall have the meanings assigned to such terms in the Plan and/or the Program.
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • May 3rd, 2013 • Amgen Inc • Biological products, (no disgnostic substances) • California
This Consulting Services Agreement (“Agreement”) is entered into as of January 25, 2013 (“Retirement Date”) by and between Fabrizio Bonanni (“Consultant”) and Amgen Inc., together with its affiliates and subsidiaries (“Amgen”).
AMENDMENT NUMBER 4 TO THE INTEGRATED FACILITIES MANAGEMENT SERVICES AGREEMENT BETWEEN JONES LANG LASALLE AMERICAS, INC. AND AMGEN INC.Management Services Agreement • May 3rd, 2013 • Amgen Inc • Biological products, (no disgnostic substances)
This Amendment Number 4 (“Amendment 4”) is entered into as of March 20, 2013 by and between Jones Lang LaSalle Americas, Inc. (“Provider”) and Amgen Inc. (“Company”).
